About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Not Yet RecruitingNCT06635525

IMPACT OF KIDNEY FAILURE ON THE REGULATION OF HUMORAL RESPONSE TO VACCINATION

The aim of this observational study is to determine if and how kidney failure affects the development of protective immune responses following vaccination in patients on chronic dialysis. Researchers...

Lead sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico•3 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Contacts

Manuel A Podesta', MD, PhD

CONTACT

0039 0255034568 manuel.podesta@policlinico.mi.it

Giuseppe Castellano, MD, PhD

CONTACT

giuseppe.castellano@policlinico.mi.it

Sponsors

Lead Sponsor

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Collaborators

Fondazione Cariplo

Age

18 - 70 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Age between 18 and 70 years
•Patients undergoing thrice-weekly hemodialysis / peritoneal dialysis for at least 3 months OR healthy individuals without a history of renal insufficiency
•Subjects eligible to receive a seasonal influenza vaccine
•Signed informed consent for participation in the study

Exclusion Criteria

•Recent influenza infection (clinically resolved less than 3 months ago).
•Administration of immunosuppressive drugs in the two weeks prior to vaccination.
•Administration of another vaccine in the three weeks prior to enrollment (co-administration of other vaccines with those under study does not contraindicate participation).
•Systemic infection clinically resolved less than two weeks before enrollment.

Related studies

RECRUITINGPhase 4

Antibiotics and Vaccine Immune Responses Study

NCT06148025 · Vaccine Response Impaired

DIALysis With EXpanded Solute Removal

NCT06660277 · Chronic Kidney Disease Requiring Hemodialysis, End-Stage Kidney Disease (ESKD), and more

RECRUITINGPhase 1

Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COVID-19 Vaccine

NCT06821100 · Vaccine Response, COVID-19 Vaccine, and more

Smart and Fit for Kidney Transplantation

NCT06040281 · Chronic Kidney Disease Requiring Chronic Dialysis

RECRUITINGPhase 4

Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients

NCT05060991 · COVID-19, Immunosuppression, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 10, 2024Terms

Trial snapshot

StatusNOT_YET_RECRUITING

Phase—

Enrollment146

Start dateOct 2024

Last updatedOct 10, 2024

Condition

Chronic Kidney Disease Requiring Chronic Dialysis Vaccine Response

Locations shown

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Milan

ASST Santi Paolo e Carlo

Milan

ASST Fatebenefratelli Sacco

Milan

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 10, 2024Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions